|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Anogen is actively pursuing the approval of our Hormone Elisa Kits by Health Canada as Class III Medical Devices for in vitro use. As such, we are seeking qualified individuals and syndicates within Canada, the United States and Europe, who are interested in receiving 50% off their initial diagnostic ELISA kit purchase. In turn, you will be responsibly for providing Anogen with testing results which may include, but is not limited to Investigator's/Clinical report, clinical data, and comparative studies.
Kits will only be granted if the research will lead to possible approval of the kit as a Medical Device by Health Canada. In doing so, we will be granting the kits for large research projects only to ensure statistical significance (20+ kits, 96 tests per kit, to be tested on human samples).
If you only require a few kits for unique testing purposes, we urge you to employ our kits at our Samples Discount. Below is a listing of the Hormone Elisa Kits available for joint testing applications:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
